| CASE REPORT |
|
| Year : 2020 | Volume
: 15
| Issue : 1 | Page : 41-43 |
|
|
Organizing pneumonia in a carrier of human T-cell lymphotropic virus type-1
Masahiro Yamasaki1, Masaya Taniwaki1, Kunihiko Funaishi2, Noboru Hattori3
1 Department of Respiratory Medicine, Hiroshima Red Cross Hospital and Atomic-Bomb Survivors Hospital, Naka-ku, Japan
2 Department of Internal Medicine, Mihara Medical Associations Hospital, Mihara, Japan
3 Department of Molecular and Internal Medicine, Institute of Biomedical and Health Sciences, Hiroshima University, Minami-ku, Hiroshima, Japan
Correspondence Address:
Dr. Masahiro Yamasaki
1-9-6 Senda-Machi, Naka-ku, Hiroshima 730-8619
Japan
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/atm.ATM_204_19
|
|
|
Human T-cell lymphotropic virus type-1 (HTLV-1)-associated bronchioloalveolar disorders (HABAs) are pulmonary disorders with various interstitial lung disease patterns that often occur in HTLV-1 carriers. Among HABAs, organizing pneumonia (OP) is extremely rare. We present a case of an 82-year-old woman with OP as a HABA. This patient responded to corticosteroid therapy; however, the patient required the continuation of oral corticosteroid therapy to avoid OP relapse. In cases of OP as a HABA that are not stabilized by treatment with corticosteroids, continuation of oral corticosteroid therapy might be considered.
|
|
|
|
| [FULL TEXT] [PDF]* |
|
 |
|
